Zobrazeno 1 - 10
of 2 179
pro vyhledávání: '"spontaneous reporting"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Tolvaptan-associated hepatic disorder is a rare, but lethal adverse event; however, the precise risk and time of onset remain unclear. This study aimed to characterize the severity, time‑to‑onset, and outcomes of hepatic disorder based o
Externí odkaz:
https://doaj.org/article/9e08396737fb4812ad71000cb8037e4b
Autor:
E. V. Shubnikova
Publikováno v:
Безопасность и риск фармакотерапии, Vol 12, Iss 3, Pp 309-330 (2024)
INTRODUCTION. Postmarketing surveillance is the main mechanism to monitor and evaluate the safety of drugs approved for widespread clinical use. This mechanism provides up-to-date information on adverse drug reactions and facilitates the implementati
Externí odkaz:
https://doaj.org/article/4627d7be30994585930da3fb93840522
Publikováno v:
Vascular Health and Risk Management, Vol Volume 20, Pp 415-420 (2024)
Mariko Kozaru, Hiroko Kambara, Akari Higuchi, Tatsuki Kagatsume, Keiko Hosohata Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, JapanCorrespondence: Ke
Externí odkaz:
https://doaj.org/article/b61c939650e645acb2715f0d048cdeb7
Publikováno v:
Frontiers in Drug Safety and Regulation, Vol 4 (2024)
Electronic health records (EHRs) have emerged as resources for both the identification of adverse drug events (ADEs) and general population health surveillance, however questions remain around how best to utilize EHR data for drug safety signal ident
Externí odkaz:
https://doaj.org/article/8b86ed7aeb82437fba2d0273e12a669d
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionVascular endothelial growth factor (VEGF) is key to wet age-related macular degeneration (wAMD). Anti-VEGF drugs are the main treatment in clinics. This study assessed ocular adverse events (AE) from anti-VEGF drugs in VigiAccess, WHO’s
Externí odkaz:
https://doaj.org/article/b0a188160ce0496ea05dfed00c658ba9
Publikováno v:
Journal of Arrhythmia, Vol 39, Iss 6, Pp 928-936 (2023)
Abstract Background Drug‐induced life‐threatening ventricular arrhythmias including torsade de pointes (TdP), ventricular tachycardia (VT), and ventricular fibrillation (VF) are serious cardiac side effects. Psychotherapeutic drugs are known to b
Externí odkaz:
https://doaj.org/article/6ef3095dd8e746648e1f348d59048d3b
Publikováno v:
Clinical Ophthalmology, Vol Volume 17, Pp 3645-3653 (2023)
Mariko Kozaru, Tatsuya Iida, Keiko Hosohata Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, JapanCorrespondence: Keiko Hosohata, Education and Research
Externí odkaz:
https://doaj.org/article/26bc72e9ed534f4a99c000dda9187ec8
Publikováno v:
Pharmaceuticals, Vol 17, Iss 8, p 1099 (2024)
Specific drugs are well known to have the capacity to induce Parkinson-like symptoms. Parkinson-like events are side effects that may persist for an extended period even after drug administration is discontinued. Although these events can be triggere
Externí odkaz:
https://doaj.org/article/a554355126c64801a9126a68ec4ac47b
The readiness of the spontaneous reporting system for COVID-19 vaccines safety monitoring in Croatia
Publikováno v:
Acta Pharmaceutica, Vol 73, Iss 2, Pp 293-310 (2023)
We aimed to identify whether a spontaneous reporting system (SRS) in Croatia could timely identify and confirm signals for COVID-19 vaccines. Post-marketing spontaneous reports of adverse drug reactions (ADRs) following COVID-19 immunisation reported
Externí odkaz:
https://doaj.org/article/d78d1c64e1854500b2c9b581d1faca2c
Publikováno v:
Borneo Journal of Pharmacy, Vol 7, Iss 1 (2024)
Drug safety is a significant concern in many countries, as side effects (AE) and adverse drug reactions (ADR) have caused many deaths worldwide. One of the reasons is the low contribution of pharmacists in spontaneously reporting AE/ADR. This study a
Externí odkaz:
https://doaj.org/article/401346103481428ea954c108ce34c4b8